StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$26.49−0.91 (-3.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

IDEAYA Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

IDEAYA Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$216.95M. For fiscal 2025 it was -$159.31M. The highest annual figure on record is -$14.44M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$159.31M–
FY2024Dec 31, 2024-$326.98M–
FY2023Dec 31, 2023-$134.43M–
FY2022Dec 31, 2022-$62.50M–
FY2021Dec 31, 2021-$50.27M–
FY2020Dec 31, 2020-$35.34M–
FY2019Dec 31, 2019-$44.27M–
FY2018Dec 31, 2018-$36.42M–
FY2017Dec 31, 2017-$14.44M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$122.29M–
Q1 FY2026Mar 31, 2026-$108.54M–
Q4 FY2025Dec 31, 2025-$94.57M–
Q3 FY2025Sep 30, 2025$108.45M–
Q2 FY2025Jun 30, 2025-$88.81M–
Q1 FY2025Mar 31, 2025-$84.39M–
Q4 FY2024Dec 31, 2024-$144.14M–
Q3 FY2024Sep 30, 2024-$66.89M–
Q2 FY2024Jun 30, 2024-$64.93M–
Q1 FY2024Mar 31, 2024-$51.02M–
Q4 FY2023Dec 31, 2023-$41.92M–
Q3 FY2023Sep 30, 2023-$33.53M-5179.7%
Q2 FY2023Jun 30, 2023-$32.71M–
Q1 FY2023Mar 31, 2023-$26.28M–
Q4 FY2022Dec 31, 2022-$26.44M–
Q3 FY2022Sep 30, 2022$660.00K–
Q2 FY2022Jun 30, 2022-$22.50M–
Q1 FY2022Mar 31, 2022-$14.22M–
Q4 FY2021Dec 31, 2021-$18.37M–
Q3 FY2021Sep 30, 2021-$11.71M–
Q2 FY2021Jun 30, 2021-$11.05M–
Q1 FY2021Mar 31, 2021-$9.14M–
Q4 FY2020Dec 31, 2020-$5.28M–
Q3 FY2020Sep 30, 2020-$5.00M–
Q2 FY2020Jun 30, 2020-$12.59M–
Q1 FY2020Mar 31, 2020-$12.48M–
Q4 FY2019Dec 31, 2019-$11.32M–
Q3 FY2019Sep 30, 2019-$11.62M–
Q2 FY2019Jun 30, 2019-$11.24M–
Q1 FY2019Mar 31, 2019-$10.09M–
Q4 FY2018Dec 31, 2018-$9.13M–
Q3 FY2018Sep 30, 2018-$13.63M–
Q2 FY2018Jun 30, 2018-$7.57M–

More IDEAYA Biosciences figures

See a number that looks wrong?